| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vinings Holdings Inc (PINK: COEP)
COEP Technical Analysis
5
| As on 9th Jun 2023 COEP STOCK Price closed @ 1.52 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.49 & Strong Sell for SHORT-TERM with Stoploss of 5.43 we also expect STOCK to react on Following IMPORTANT LEVELS. |
COEPSTOCK Price
| Open | 1.57 | Change | Price | % |
| High | 1.66 | 1 Day | -0.08 | -5.00 |
| Low | 1.51 | 1 Week | -0.45 | -22.84 |
| Close | 1.52 | 1 Month | 0.19 | 14.29 |
| Volume | 552600 | 1 Year | -2.97 | -66.15 |
| 52 Week High 7.90 | 52 Week Low 1.03 | ||||
PINK USA Most Active Stocks
| CNNA | 0.01 | 0.00% |
| AITX | 0.01 | 0.00% |
| TXGE | 1826.91 | -1.55% |
| CAVR | 0.01 | % |
| ENZC | 0.05 | 25.00% |
| OZSC | 0.01 | 0.00% |
| DPLS | 0.01 | 0.00% |
| WRFX | 0.01 | % |
| AMXVF | 1.05 | 10.53% |
| AABB | 0.03 | 0.00% |
PINK USA Top Gainers Stocks
PINK USA Top Losers Stocks
| COEP Daily Charts |
COEP Intraday Charts |
Whats New @ Bazaartrend |
COEP Free Analysis |
|
|
COEP Important Levels Intraday
| RESISTANCE | 1.81 |
| RESISTANCE | 1.72 |
| RESISTANCE | 1.66 |
| RESISTANCE | 1.60 |
| SUPPORT | 1.44 |
| SUPPORT | 1.38 |
| SUPPORT | 1.32 |
| SUPPORT | 1.23 |
COEP Forecast May 2024
| 4th UP Forecast | 12.12 |
| 3rd UP Forecast | 8.72 |
| 2nd UP Forecast | 6.62 |
| 1st UP Forecast | 4.52 |
| 1st DOWN Forecast | -1.48 |
| 2nd DOWN Forecast | -3.58 |
| 3rd DOWN Forecast | -5.68 |
| 4th DOWN Forecast | -9.08 |
COEP Weekly Forecast
| 4th UP Forecast | 3.89 |
| 3rd UP Forecast | 3.13 |
| 2nd UP Forecast | 2.66 |
| 1st UP Forecast | 2.19 |
| 1st DOWN Forecast | 0.85 |
| 2nd DOWN Forecast | 0.38 |
| 3rd DOWN Forecast | -0.09 |
| 4th DOWN Forecast | -0.85 |
COEP Forecast2024
| 4th UP Forecast | 22.91 |
| 3rd UP Forecast | 16.05 |
| 2nd UP Forecast | 11.81 |
| 1st UP Forecast | 7.57 |
| 1st DOWN Forecast | -4.53 |
| 2nd DOWN Forecast | -8.77 |
| 3rd DOWN Forecast | -13.01 |
| 4th DOWN Forecast | -19.87 |
Vinings Holdings Inc ( PINK USA Symbol : COEP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
COEP Business Profile
Vinings Holdings Inc., a biopharmaceutical company, engages in the acquisition, development, and commercialization of branded and generic pharmaceutical products. Its product portfolio consists of two approved drugs and two clinical stage drugs. The company offers Conjupri (levamlodipine) tablets for the treatment of hypertension; and Consensi (amlodipine and celecoxib) tablets to treat pain caused by osteoarthritis. Its clinical-stage drug candidates include CPT15050; and CPT60621, a focus on Parkinson's Disease. The company has partnership with Burke Therapeutics for sales, marketing, distribution, contracting, and pricing for conjupri; and partnership with Vici Health Sciences, LLC and Coeptis Pharmaceuticals would co-develop and share ownership rights to CPT60621. The company is based in Wexford, Pennsylvania. Address: 105 Bradford Road, Wexford, PA, United States, 15090
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service